Pages that link to "Q415178"
Jump to navigation
Jump to search
The following pages link to ivermectin (Q415178):
Displaying 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- scabies (Q167178) (← links)
- dirofilariasis (Q443929) (← links)
- rosacea (Q831530) (← links)
- ascariasis (Q842428) (← links)
- onchocerciasis (Q1137321) (← links)
- lice infestation (Q1343674) (← links)
- trichuriasis (Q2264130) (← links)
- strongyloidiasis (Q2360849) (← links)
- gnathomiasis (Q2665559) (← links)
- anisakiasis (Q3091959) (← links)
- mansonelliasis (Q4280605) (← links)
- syngamosis (Q4420034) (← links)
- scaly foot (Q7429850) (← links)
- elephantiasis (Q16775468) (← links)
- Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal (Q21144535) (← links)
- Of mice, cattle, and humans: the immunology and treatment of river blindness (Q21144551) (← links)
- Treatment of rabbit cheyletiellosis with selamectin or ivermectin: a retrospective case study (Q21202819) (← links)
- Short Communication: In Vitro Efficacy Testing of Praziquantel, Ivermectin, and Oxfendazole against Taenia Solium Cysts (Q21296654) (← links)
- Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study (Q21562277) (← links)
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection (Q24186446) (← links)
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis (Q24186468) (← links)
- Doxycycline plus ivermectin versus ivermectin alone for treating onchocerciasis (Q24194317) (← links)
- Ivermectin versus benzimidazoles for treating strongyloides infection (Q24197775) (← links)
- Ivermectin for onchocercal eye disease (river blindness) (Q24201374) (← links)
- Azoles and ivermectin for treating strongyloides infection (Q24240275) (← links)
- Alberta. Suspected ivermectin toxicity in kittens (Q24548396) (← links)
- Mechanism of ivermectin facilitation of human P2X4 receptor channels (Q24644507) (← links)
- Efficacy of Ivermectin against Cheyletiella yasguri Infestation in Dogs (Q24672745) (← links)
- Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa (Q24799577) (← links)
- Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis (Q24799885) (← links)
- Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity (Q24813874) (← links)
- Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin (Q25257764) (← links)
- New developments in the treatment of rosacea - role of once-daily ivermectin cream (Q26751296) (← links)
- Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review (Q26782693) (← links)
- Ivermectin 1% cream for rosacea (Q26783537) (← links)
- Allosteric modulation of ligand gated ion channels by ivermectin (Q26866548) (← links)
- Causal Interrogation of Neuronal Networks and Behavior through Virally Transduced Ivermectin Receptors. (Q27308720) (← links)
- Interactions of L-3,5,3'-Triiodothyronine [corrected], Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes (Q27316335) (← links)
- Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole (Q27329637) (← links)
- The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism (Q27684737) (← links)
- Elimination of human onchocerciasis: History of progress and current feasibility using ivermectin (Mectizan®) monotherapy (Q27692519) (← links)
- Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP. (Q27972966) (← links)
- Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments (Q28072685) (← links)
- Ivermectin toxicosis in three adult horses (Q28256970) (← links)
- Effect of ivermectin on function of liver macrophages (Q28289192) (← links)
- Ivermectin excretion by isolated functionally intact brain endothelial capillaries (Q28346485) (← links)
- Genome-wide SNP analysis using 2b-RAD sequencing identifies the candidate genes putatively associated with resistance to ivermectin in Haemonchus contortus (Q28468305) (← links)
- Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa (Q28468413) (← links)
- Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment (Q28469339) (← links)